Portfolio map · Private equity · United States
Northpond Ventures portfolio map
30 startups Northpond Ventures has backed in rounds we track, since 2018, grouped by their main sector. Together they have raised $1.7B; Northpond Ventures led at least one round in 8 of them. The biggest sector is Biotech, with 24 companies.
Biotech
24
908 Devices
Vigil Neuroscience- SSpeeDx
Code Biotherapeutics
Telesis Bio
Sherlock Biosciences
SeLux Diagnostics
VizgenChromaCode
Aro Biotherapeutics
IsoPlexis
Kytopen
Refeyn- SSGI-DNA
Candel Therapeutics
Deep Lens
Slingshot Biosciences
SimBioSys
Transition Bio
QbDVision
Intabio
EnPlusOne Biosciences
Nanoview Biosciences
Isolere Bio
Funding by segment
- Biotech$1.1B24
- AI$104M3
- Pharma$536M3
Where they are based
- United States27$1.1B
- United Kingdom2$472M
- Australia1$122M
United States
United Kingdom
AustraliaFounded
2 without a founding year on record.
Total raised
- Under $1M1
- $1M to $10M1
- $10M to $50M20
- $50M to $250M7
- $250M to $1B1
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
27 of 30 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States27
- United Kingdom2
- Australia1
Startups by country, 3 countries in all.
Segment by segment
Biotech
24 startups · $1.1B raised
- 908 Devices908devices manufactures battery-operated, hand-held chemical detection tools used in mass spectrometry.United States$168M
- Vigil NeuroscienceVigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.United States$130M
- SSpeeDxAustralia$122M
- Code BiotherapeuticsCode Biotherapeutics (Code Bio) is a biotechnology company founded in 2020, based in Hatfield, Pennsylvania.United States$75M
- Telesis BioTelesis Bio is a biotech company that empowers researchers with the tools to secure design, code, and create synthetic DNA and mRNA.United States$74M
- Sherlock BiosciencesSherlock Biosciences is an engineering biology company offering unparalleled breadth and versatility for diagnostic solutions.United States$66M
- SeLux DiagnosticsSeLux Diagnostics is a developer of a next-generation phenotyping platform that provides personalized antimicrobial therapies to patients.United States$48M
- VizgenVizgen is a biotechnology company founded in 2019, based in Waltham, Massachusetts, with research and development operations in CaUnited States$48M
AI
3 startups · $104M raised
VieCureVieCure Inc.United States$43M
ElephasElephas Biosciences Corporation, based in Madison, Wisconsin, is a clinical-stage biotechnology company focused on precision oncolUnited States$40M
Outcomes4MeOutcomes4Me is a Boston-based, AI-driven patient empowerment platform founded in 2017.United States$21M
Pharma
3 startups · $536M raised
OMass TherapeuticsOMass Therapeutics is a biotechnology company located in Oxford, UK, focused on discovering and developing novel small molecule meUnited Kingdom$442M
Totus MedicinesTotus Medicines is a clinical-stage biotechnology company located in Emeryville, California.United States$66M
UltivueUltivue is a biotechnology company that specializes in tissue imaging, diagnostics, and multiplexing.United States$28M
How this map is made. Every startup here has raised money in a round we track that names Northpond Ventures as an investor, the first in 2018. Each sits under its main sector, read from its rounds, and each sector shows its best-funded first; sectors with fewer than three companies are left off. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like Northpond Ventures?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.